Genetics of iron regulation and the possible role of iron in Parkinson's disease

被引:90
作者
Rhodes, Shannon L. [1 ]
Ritz, Beate [2 ]
机构
[1] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA
[2] Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
关键词
Parkinson's disease; Iron regulatory proteins; Genetics; Pathogenesis;
D O I
10.1016/j.nbd.2008.07.001
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is acknowledged as the second most common neurodegenerative disorder after Alzheimer's Disease. Older age may be the only unequivocal risk factor for PD although the male to female ratio is consistently greater than 1 in populations of European ancestry. Characteristic features of PD include dopaminergic neuron death in the substantia nigra (SN) pars compacta, accumulation of alpha-synuclein inclusions known as Lewy bodies in the SN, and brain iron accumulation beyond that observed in non-PD brains of a similar age. In this review article, we will provide an overview of human and animal studies investigating the contributions of iron in PD, a summary of human studies of iron-related genes in PD, a review of the literature on the genetics of iron metabolism, and some hypotheses on possible roles for iron in the pathogenic processes of PD including potential interactions between iron and other factors associated with Parkinson's disease. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:183 / 195
页数:13
相关论文
共 209 条
  • [1] Prevalence of haemochromatosis gene mutations in Parkinson's disease
    Aamodt, Anne Hege
    Stovner, Lars Jacob
    Thorstensen, Ketil
    Lydersen, Stian
    White, Linda R.
    Aasly, Jan O.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (03) : 315 - 317
  • [2] EPR investigations of the iron domain in neuromelanin
    Aime, S
    Bergamasco, B
    Biglino, D
    Digilio, G
    Fasano, M
    Giamello, E
    Lopiano, L
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1361 (01): : 49 - 58
  • [3] Screening for mutations of the HFE gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra
    Akbas, Nilguen
    Hochstrasser, Helmine
    Deplazes, Joelle
    Tomiuk, Juergen
    Bauer, Peter
    Walter, Uwe
    Behnke, Stefanie
    Riess, Olaf
    Berg, Daniela
    [J]. NEUROSCIENCE LETTERS, 2006, 407 (01) : 16 - 19
  • [4] Oxidative stress in neurodegeneration: cause or consequence?
    Andersen, JK
    [J]. NATURE MEDICINE, 2004, 10 (07) : S18 - S25
  • [5] Anderson C, 1999, MOVEMENT DISORD, V14, P21, DOI 10.1002/1531-8257(199901)14:1&lt
  • [6] 21::AID-MDS1006&gt
  • [7] 3.0.CO
  • [8] 2-Y
  • [9] NORMAL DEPOSITION OF BRAIN IRON IN CHILDHOOD AND ADOLESCENCE - MR IMAGING AT 1.5 T
    AOKI, S
    OKADA, Y
    NISHIMURA, K
    BARKOVICH, AJ
    KJOS, BO
    BRASCH, RC
    NORMAN, D
    [J]. RADIOLOGY, 1989, 172 (02) : 381 - 385
  • [10] Ceruloplasmin ferroxidase activity stimulates cellular iron uptake by a trivalent cation-specific transport mechanism
    Attieh, ZK
    Mukhopadhyay, CK
    Seshadri, V
    Tripoulas, NA
    Fox, PL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (02) : 1116 - 1123